Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06407947
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-06
Brief Title:
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
Sponsor:
Shanghai Changzheng Hospital
Organization:
Shanghai Changzheng Hospital
Study Overview
Official Title:
Exploratory Clinical Trial of the Safety and Efficacy of CT071 Injection in Patients With High Risk Newly Diagnosed Multiple Myeloma
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is a single-arm single-center open-label clinical trial to evaluate the safety efficacy and metabolism kinetics of CT071 in patients with high-risk newly diagnosed multiple myeloma
Detailed Description:
This trial is a single-arm single-center open-label clinical trial to evaluate the safety efficacy and metabolism kinetics of CT071 in patients with high-risk newly diagnosed multiple myeloma HRNDMM
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None